← Open Payments lookup

ASHLEY MARTIN: Open Payments

NPI 1932723103 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,211 in 10 payments from 10 companies in 2025. Trend: 2023 $298 · 2024 $568 · 2025 $1,211

Food & beverage: $1,211
CompanyPaymentsAmount
Dexcom, Inc.1$163
Abbott Laboratories1$163
Edwards Lifesciences Corporation1$125
AstraZeneca Pharmaceuticals LP1$125
Novo Nordisk Inc1$123
Teva Pharmaceuticals USA, Inc.1$123
Madrigal Pharmaceuticals1$123
Gilead Sciences, Inc.1$121
GENZYME CORPORATION1$120
Takeda Pharmaceuticals U.S.A., Inc.1$24

Products named: DEXCOM G7 GSS (161), FREESTYLE LIBRE 3, WAINUA, Wegovy, AUSTEDO XR, REZDIFFRA, FABRAZYME, ICLUSIG.

Industry payments across LA — which companies pay providers there.